MediPal Holdings Corporation
7459.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | ¥952,403,000 | ¥945,159,000 | ¥864,156,000 | ¥982,500,000 |
| % Growth | 0.8% | 9.4% | -12% | – |
| Cost of Goods Sold | ¥890,171,000 | ¥880,481,000 | ¥806,025,000 | ¥914,716,000 |
| Gross Profit | ¥62,232,000 | ¥64,678,000 | ¥58,131,000 | ¥67,784,000 |
| % Margin | 6.5% | 6.8% | 6.7% | 6.9% |
| R&D Expenses | ¥0 | ¥0 | ¥0 | ¥0 |
| G&A Expenses | ¥0 | ¥41,075,000 | ¥42,151,000 | ¥40,206,000 |
| SG&A Expenses | ¥51,203,000 | ¥47,267,000 | ¥47,893,000 | ¥46,194,000 |
| Sales & Mktg Exp. | ¥0 | ¥6,192,000 | ¥5,747,000 | ¥5,988,000 |
| Other Operating Expenses | ¥0 | ¥3,358,000 | ¥0 | ¥3,380,000 |
| Operating Expenses | ¥51,203,000 | ¥50,625,000 | ¥47,893,000 | ¥49,574,000 |
| Operating Income | ¥11,029,000 | ¥14,053,000 | ¥10,238,000 | ¥18,210,000 |
| % Margin | 1.2% | 1.5% | 1.2% | 1.9% |
| Other Income/Exp. Net | ¥10,114,000 | ¥4,612,000 | ¥553,000 | ¥7,958,000 |
| Pre-Tax Income | ¥21,143,000 | ¥18,665,000 | ¥10,791,000 | ¥26,168,000 |
| Tax Expense | ¥6,271,000 | ¥6,054,000 | ¥4,488,000 | ¥8,510,000 |
| Net Income | ¥12,504,000 | ¥9,586,000 | ¥4,042,000 | ¥14,511,000 |
| % Margin | 1.3% | 1% | 0.5% | 1.5% |
| EPS | 60.63 | 46.17 | 19.43 | 69.78 |
| % Growth | 31.3% | 137.6% | -72.2% | – |
| EPS Diluted | 60.63 | 46.17 | 19.43 | 69.78 |
| Weighted Avg Shares Out | 206,236 | 207,628 | 207,960 | 207,950 |
| Weighted Avg Shares Out Dil | 206,236 | 207,628 | 207,960 | 207,950 |
| Supplemental Information | – | – | – | – |
| Interest Income | ¥88,000 | ¥0 | ¥35,000 | ¥3,000 |
| Interest Expense | ¥3,000 | ¥3,000 | ¥2,000 | ¥2,000 |
| Depreciation & Amortization | ¥4,620,000 | ¥3,353,000 | ¥4,646,000 | ¥4,625,000 |
| EBITDA | ¥25,769,000 | ¥17,411,000 | ¥15,442,000 | ¥30,797,000 |
| % Margin | 2.7% | 1.8% | 1.8% | 3.1% |